A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER2-Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Eligible for screening study DCP 001
BR007, HRQOL Sub-study, is closed to accrual, effective April 24, 2023.
